Ligand validation:3EJD

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 3EJD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EJD_HTG_A_100	42%	9%	0.154	0.912	3.37	1.11	2	1	0	0	79%	0.7895
3EJD_HTG_G_100	37%	69%	0.136	0.898	0.3	0.88	-	-	0	0	63%	0.6316
3EJD_HTG_E_100	33%	72%	0.13	0.872	0.32	0.74	-	-	0	0	63%	0.6316
3EJD_HTG_C_100	23%	72%	0.16	0.85	0.31	0.75	-	-	0	0	63%	0.6316
3EJD_HTG_D_417	14%	70%	0.156	0.84	0.56	0.59	-	-	1	0	26%	0.2632
3EJD_HTG_H_417	9%	32%	0.203	0.805	1.52	1.2	1	1	1	0	37%	0.3684
3EJD_HTG_A_101	9%	66%	0.173	0.769	0.65	0.67	-	-	1	0	37%	0.3684
3EJD_HTG_F_417	7%	68%	0.251	0.831	0.63	0.61	-	-	0	0	32%	0.3158
3EJB_HTG_G_100	62%	6%	0.093	0.922	3.76	1.37	2	1	0	0	79%	0.7895
3EJE_HTG_C_100	40%	74%	0.153	0.929	0.31	0.69	-	-	0	0	63%	0.6316
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.